tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Morning Movers: PepsiCo gains following second quarter results
PremiumThe FlyMorning Movers: PepsiCo gains following second quarter results
12d ago
Novartis reports Q2 EPS core $2.42, consensus $2.37
Premium
The Fly
Novartis reports Q2 EPS core $2.42, consensus $2.37
12d ago
Novartis sees FY25 sales up high single digits
Premium
The Fly
Novartis sees FY25 sales up high single digits
12d ago
Novartis loses bid to block MSN generic of Entresto, Bloomberg says
PremiumThe FlyNovartis loses bid to block MSN generic of Entresto, Bloomberg says
18d ago
FDA willing to trade faster drug reviews for lower prices, Bloomberg reports
Premium
The Fly
FDA willing to trade faster drug reviews for lower prices, Bloomberg reports
18d ago
Pan-Tumor Rollover Study: A New Horizon in Cancer Treatment
Premium
Company Announcements
Pan-Tumor Rollover Study: A New Horizon in Cancer Treatment
20d ago
GSK completes acquisition of efimosfermin alfa from Boston Pharmaceuticals
PremiumThe FlyGSK completes acquisition of efimosfermin alfa from Boston Pharmaceuticals
22d ago
Novartis’ RED4MS Trial: A New Hope for Multiple Sclerosis Treatment?
Premium
Company Announcements
Novartis’ RED4MS Trial: A New Hope for Multiple Sclerosis Treatment?
26d ago
Novartis reports GCAptAIN study did not meet primary endpoint
Premium
The Fly
Novartis reports GCAptAIN study did not meet primary endpoint
26d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100